12936
A Phase 2a Study Of Safety, PK, And PD Of NTRX-07, A Cannabinoid CB2 Agonist, In MCI Or Early Alzheimer's Disease
Joseph Foss, Marianna Kiraly, Tony Giordano, Nily Osman, Peter Kovacs, Gabor Csukly
NeuroTherapia, Inc., Cleveland Clinic, Cleveland, OH, USA., NeuroTherapia, Inc, Cleveland, OH, USA., Osman Clinical Partners, Nevada, USA, CRU Global, Inc., Budapest, Hungary
Poster Presenter: Joseph Foss